[1] Dai J, Liao N, Shi J, et al. Study of prevalence and influencing factors of depression in tumor patients and the therapeutic effects of fluoxetine[J]. Eur Rev Med Pharmacol Sci, 2017, 21(21): 4966-4974.
[2] Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients[J]. Int J Radiat Oncol Biol Phys, 2002, 53(3): 664-674. DOI: 10.1016/s0360-3016(02)02764-5.
[3] 钮东峰, 薛卫成. 直肠癌新辅助治疗后病理评估[J]. 中华胃肠外科杂志, 2018, 21(6): 632-636. DOI: 10.3760/cma.j.issn.1671-0274.2018.06.003.
[4] Barbaro B, Vitale R, Leccisotti L, et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy[J]. Radiographics, 2010, 30(3): 699-716. DOI: 10.1148/rg.303095085.
[5] Kino A, Shaffer J, Maturen KE, et al. Perfusion CT measurements predict tumor response in rectal carcinoma[J]. Abdom Radiol (NY), 2017, 42(4): 1132-1140. DOI: 10.1007/s00261-016-0983-5.
[6] Sun Y, Xiao Q, Hu F, et al. Diffusion kurtosis imaging in the characterisation of rectal cancer: utilizing the most repeatable region-of-interest strategy for diffusion parameters on a 3T scanner[J]. Eur Radiol, 2018, 28(12): 5211-5220. DOI: 10.1007/s00330-018-5495-y.
[7] CurvoSemedo L, Portilha MA, Ruivo C, et al. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer[J]. Acad Radiol, 2012, 19(2): 203-213. DOI: 10.1016/j.acra.2011.10.019.
[8] 周志鹏, 汤日杰, 李建生, 等. 直肠癌多层螺旋CT灌注参数与临床病理特征的相关性研究[J]. 中国CT和MRI杂志, 2017, 15(11): 113-115, 124. DOI: 10.3969/j.issn.1672-5131.2017.11.034.
[9] Losi L, Luppi G, Gavioli M, et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy[J]. Int J Colorectal Dis, 2006, 21(7): 645-651. DOI: 10.1007/s00384-005-0061-x.
[10] 余涛, 安琦, 曹祥龙, 等. 中低位局部进展期直肠癌新辅助放化疗后肿瘤消退分级的预测因素研究[J]. 中华实验外科杂志, 2018, 35(3): 536-538. DOI: 10.3760/cma.j.issn.1001-9030.2018.03.043.
[11] Krajnovi′c M, Markovi′c B, Kneˇzevi′c-Uˇzaj S, et al. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics[J]. Pathol Res Pract, 2016, 212(7): 598-603. DOI: 10.1016/j.prp.2016.02.018.
[12] Del Gobbo A, Ferrero S. Immunohistochemical markers as predictors of histopathologic response and prognosis in rectal cancer treated with preoperative adjuvant therapy: state of the art[J]. Gastroenterol Res Pract, 2017, 2017: 2808235. DOI: 10.1155/2017/2808235.
[13] Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations[J]. Radiology, 2005, 234(3): 785-792. DOI: 10.1148/radiol.2343040286.
[14] Watanabe J, Ota M, Kawaguchi D, et al. Incidence and risk factors for rectovaginal fistula after low anterior resection for rectal cancer[J]. Int J Colorectal Dis, 2015, 30(12): 1659-1666. DOI: 10.1007/s00384-015-2340-5.
[15] Kan Z, Phongkitkarun S, Kobayashi S, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model[J]. Radiology, 2005, 237(1): 151-158. DOI: 10.1148/radiol.2363041293.
[16] Sun LL, Song Z, Li WZ, et al. Hypoxia facilitates epithelial-mesenchymal transition-mediated rectal cancer progress[J]. Genet Mol Res, 2016, 15(4). DOI: 10.4238/gmr15048936.
[17] Iv M, Fischbein NJ, Zaharchuk G. Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging[J]. J Neuroimaging, 2015, 25(2): 243-250. DOI: 10.1111/jon.12119.
[18] Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience[J]. Radiology, 2007, 244(2): 486-493. DOI: 10.1148/radiol.2442061189. |